Our Vision is to Save Visions

Ophthalytics is a revolutionary AI-based diagnostic platform for eye diseases, currently under FDA clearance. The platform has multiple service offerings that autonomously detect highly complex eye-related diseases, including the vision-threatening disease like Diabetic Retinopathy.

Diabetic Retinopathy 

The eyes are one of the most complex parts of the human body, requiring continuous care throughout our lives. Protecting this vital can improve the quality of life. One way to do that is by catching diseases early enough to treat them. Late detection of certain eye diseases can surpass temporary damage, potentially causing Vision Impairment or permanent blindness.

Diabetic Retinopathy is one of the leading causes of vision hindrance and blindness among the working-class population, especially in the United States. The number of Americans diagnosed with Diabetic Retinopathy continues to rise.



Microaneurysms are the earliest clinically visible changes in Diabetic Retinopathy. They are localized capillary dilatations, which are usually saccular (round). They appear as small red dots, which are often in clusters.

  • Earliest visible sign of NPDR
  • Size ranges from 15 μm to 60 μm
  • Clinically challenging to identify
  • Require highly skilled personnel
  • Very time consuming to detect
  • Increases physician’s workload and decreases efficiency

Benefits of Ophthalytics

  • Ophthalytics is the easiest, fastest, and most accurate resource in the market to utilize for DR assessment. The only assets you will need include a high-speed internet connection and a laptop/mobile/pc to access the service and reap the benefits.
  • The technology used automatically assesses the quality of the images and instantly responds if new or better-quality photos are required to produce accurate results.
  • Users can search and retrieve existing patient DR assessments from Ophthalytics at any time.
  • Save hefty amounts on unnecessary infrastructure upgrades, increase the number of patients served, and improve ROI.

Through the NVIDIA Inception Program for AI startups, Ophthalytics benefits from NVIDIA’s next-generation GPU computing capabilities and direct support, enabling us to create innovative products and services faster. AWS Activate provides several benefits for Ophthalytics, including AWS credits, AWS Support package credits, and training, to help grow our business.